BD Onclarity™ HPV Assay with extended genotyping

Learn more about the benefits of extended genotyping and the BD Onclarity™ HPV Assay, the only FDA-approved HPV test with extended genotyping, that identifies genotypes beyond 16 and 18, including 31.

Latest resources

Discover our latest articles, webinars, press releases and updates in women's health.

Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Cervical Cancer | News & Updates
Modern Healthcare: How is extended genotyping shaping the future of cervical cancer screening?
Politico article
Cervical Cancer | News & Updates
POLITICO: Women don’t know when to get screened for cervical cancer, survey finds
ReachMD: Genotype specific persistence: Looking beyond HPV 16
Cervical Cancer | Webinars & Videos
ReachMD: Genotype specific persistence: Looking beyond HPV 16